Indication
DMD-Associated Dilated Cardiomyopathy
2 clinical trials
2 products
Clinical trial
A Phase 1b, Open-Label, Controlled Trial Evaluating the Safety and Efficacy of SRD-001 (AAV1/SERCA2a) in Subjects With Cardiomyopathy Secondary to Duchenne Muscular DystrophyStatus: Not yet recruiting, Estimated PCD: 2027-02-01
Product
SRD-001Clinical trial
A Phase 2, Single-Arm, Open-Label, Multi-Center Study to Evaluate the Safety and Efficacy of TXA127/Angiotensin [1-7] in Non-Ambulant Patients With Duchenne Muscular Dystrophy (DMD) Cardiomyopathy Who Are Receiving Systemic GlucocorticoidsStatus: Recruiting, Estimated PCD: 2024-08-01
Product
talfirastide